349 related articles for article (PubMed ID: 33911289)
21. Cytokines and chemokines differentially regulate innate immune cell trafficking during post kala-azar dermal leishmaniasis.
Singh AK; Das VNR; Amit A; Dikhit MR; Mahantesh V; Singh SK; Naryan S; Pandey K; Das P; Verma N; Bimal S
J Cell Biochem; 2018 Sep; 119(9):7406-7418. PubMed ID: 29775225
[TBL] [Abstract][Full Text] [Related]
22. Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.
Kumar A; Singh VK; Tiwari R; Madhukar P; Rajneesh ; Kumar S; Gautam V; Engwerda C; Sundar S; Kumar R
Front Immunol; 2023; 14():1236952. PubMed ID: 37638047
[TBL] [Abstract][Full Text] [Related]
23. Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis.
Mukherjee S; Mukhopadhyay D; Braun C; Barbhuiya JN; Das NK; Chatterjee U; von Stebut E; Chatterjee M
Exp Dermatol; 2015 Mar; 24(3):232-4. PubMed ID: 25580856
[TBL] [Abstract][Full Text] [Related]
24. Immune Responses in Post Kala-azar Dermal Leishmaniasis.
Chatterjee M; Sengupta R; Mukhopadhyay D; Mukherjee S; Dighal A; Moulik S; Sengupta S
Indian J Dermatol; 2020; 65(6):452-460. PubMed ID: 33487699
[TBL] [Abstract][Full Text] [Related]
25. Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study.
Singh OP; Tiwary P; Kushwaha AK; Singh SK; Singh DK; Lawyer P; Rowton E; Chaubey R; Singh AK; Rai TK; Fay MP; Chakravarty J; Sacks D; Sundar S
Lancet Microbe; 2021 Jan; 2(1):e23-e31. PubMed ID: 33615281
[TBL] [Abstract][Full Text] [Related]
26. Barriers to the effective management and prevention of post kala-azar dermal leishmaniasis (PKDL) in the Indian subcontinent.
Pal B; Kumari S; Kaur M; Wadhwa P; Murti K; Kumar R; Pandey K; Siddiqui NA; Dhingra S; Padmakar S
Med J Armed Forces India; 2023; 79(5):500-505. PubMed ID: 37719909
[TBL] [Abstract][Full Text] [Related]
27. Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study.
Banjara MR; Kroeger A; Huda MM; Kumar V; Gurung CK; Das ML; Rijal S; Das P; Mondal D
Trans R Soc Trop Med Hyg; 2015 Jun; 109(6):408-15. PubMed ID: 25918216
[TBL] [Abstract][Full Text] [Related]
28. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
Zijlstra EE
Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in post-kala-azar dermal leishmaniasis.
Mondal D; Khan MG
Curr Opin Infect Dis; 2011 Oct; 24(5):418-22. PubMed ID: 21885919
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis.
Roy M; Ceruti A; Kobialka RM; Roy S; Sarkar D; Wahed AAE; Chatterjee M
PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011231. PubMed ID: 37075066
[TBL] [Abstract][Full Text] [Related]
31. Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh.
Rahman KM; Islam S; Rahman MW; Kenah E; Ghalib CM; Zahid MM; Maguire J; Rahman M; Haque R; Luby SP; Bern C
Clin Infect Dis; 2010 Jan; 50(1):73-6. PubMed ID: 19951168
[TBL] [Abstract][Full Text] [Related]
32. Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes.
Thakur CP; Kumar K
Ann Trop Med Parasitol; 1992 Aug; 86(4):355-9. PubMed ID: 1463355
[TBL] [Abstract][Full Text] [Related]
33. Clinical Proteomics Profiling for Biomarker Identification Among Patients Suffering With Indian Post Kala Azar Dermal Leishmaniasis.
Jaiswal P; Ghosh M; Patra G; Saha B; Mukhopadhyay S
Front Cell Infect Microbiol; 2020; 10():251. PubMed ID: 32528904
[No Abstract] [Full Text] [Related]
34. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
Salotra P; Singh R
Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
[TBL] [Abstract][Full Text] [Related]
35. Post-kala-azar dermal leishmaniasis.
Zijlstra EE; Musa AM; Khalil EA; el-Hassan IM; el-Hassan AM
Lancet Infect Dis; 2003 Feb; 3(2):87-98. PubMed ID: 12560194
[TBL] [Abstract][Full Text] [Related]
36. Liposomal amphotericin B is more effective in polymorphic lesions of post kala-azar dermal leishmaniasis.
Moulik S; Sengupta R; Ghosh MK; Das NK; Saha B; Chatterjee M
Indian J Dermatol Venereol Leprol; 2022; 88(2):201-206. PubMed ID: 33969651
[TBL] [Abstract][Full Text] [Related]
37. High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis.
Gasim S; Theander TG; ElHassan AM
Acta Trop; 2000 Feb; 75(1):35-8. PubMed ID: 10708005
[TBL] [Abstract][Full Text] [Related]
38. Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent.
Molina R; Ghosh D; Carrillo E; Monnerat S; Bern C; Mondal D; Alvar J
Clin Infect Dis; 2017 Jul; 65(1):150-153. PubMed ID: 28520851
[TBL] [Abstract][Full Text] [Related]
39. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
[TBL] [Abstract][Full Text] [Related]
40. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]